26 Biggest Marijuana Companies in the World

In This Article:

This article will discuss the 26 biggest marijuana companies in the world, understand some recent industry trends, and navigate the future of the marijuana industry. If you want to skip our detailed analysis, you can head directly to the 5 Biggest Marijuana Companies in the World.

An Analysis of the Cannabis Industry

According to a report by Fortune Business Insights, the global cannabis market was worth $43.72 billion in 2022. The industry is expected to reach a valuation of $57.18 billion by the end of 2023 and is projected to grow at a compound annual growth rate of 34.03% to a value of $444.34 billion by 2030.

The United States was one of the first countries to legalize the medicinal use of cannabis. Colorado and Washington were among the first to legalize the use of marijuana in 2012. This explains why North America dominated the global cannabis market and accounted for $35.67 billion of the industry's market value in 2022. According to Reuters, as of 2023, 23 states across the United States have legalized the use of cannabis for recreational purposes. Regional trends suggest that Canada is an emerging powerhouse for cannabis companies, attributable to rapid legalization and wide public acceptance. 

When we look outside the US and North American region, Europe is expected to be the second-fastest growing region when it comes to the medicinal use of cannabis products. The Asia Pacific region is also forecasted to undergo significant growth as part of changing government policies related to the medicinal use of cannabis. In June 2022, the government of Thailand lifted bans on the cultivation, production, and sale of cannabis. Moreover, identifying the therapeutic benefits of marijuana, Germany, Finland, and Israel have permitted the medicinal use of cannabis on a larger scale.

A Potential Major Player Emerges

On July 20, Forbes reported Philip Morris International Inc. (NYSE:PM) is attempting to acquire Syqe Medical for an estimated $650 million, an Israel-based cannabis company. This step will be a catalyst for the medical and cannabis industry. Upon successful completion of the clinical trials, the acquisition will take place, potentially placing Syqe Medical among the top 10 marijuana companies in the world.

The company's product is a pain reduction inhaler backed by raw medical cannabis rather than its processed versions. Additionally, with its unique and innovative features, the inhaler suggests an appropriate dosage for each patient. First-world countries such as Canada have approved the inhaler for medical use. However, the product is yet to be marketed for sale. The acquisition by Philip Morris International Inc. (NYSE:PM) will be a game changer for Syqe Medical and the global medical community.